Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China

Figure 1

Curve of the dose-effect relationship of different drugs. x axes indicate log of drug concentrations (uM), y axes indicate the inhibitor rate of virus (%). Red curve is the dose-effect relationship of control pNL4-3, dotted line is y = 50%. (A) is the dose-effect relationship of 5 viruses (K101Q/Y181C/H221Y, K101Q/Y181C, K101Q/H221Y, K101Q and pNL4-3) in NVP. (B) is the dose-effect relationship of 5 viruses (K101Q/Y181C/H221Y, K101Q/Y181C, K101Q/H221Y, K101Q and pNL4-3) in EFV. (C), (D), (E) is the dose-effect relationship of K101Q/H221Y and pNL4-3 in AZT, 3TC and d4T respectively.

Back to article page
\